1.中国中医科学院广安门医院风湿病科(北京 100053)
2.北京中医药大学研究生院(北京 100029)
徐润,女,硕士研究生,主要从事中医治疗风湿病临床研究工作
姜泉,主任医师,博士研究生导师; E-mail:doctorjq@126.com
扫 描 看 全 文
徐润,姜泉,韩曼,等.基于“心痹”理论论治类风湿关节炎的心血管损伤[J].上海中医药杂志,2022,56(11):48-52.
XU Run,JIANG Quan,HAN Man,et al.Treating cardiovascular injury of rheumatoid arthritis based on the theory of “heart paralysis”[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(11):48-52.
徐润,姜泉,韩曼,等.基于“心痹”理论论治类风湿关节炎的心血管损伤[J].上海中医药杂志,2022,56(11):48-52. DOI: 10.16305/j.1007-1334.2022.2112002.
XU Run,JIANG Quan,HAN Man,et al.Treating cardiovascular injury of rheumatoid arthritis based on the theory of “heart paralysis”[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(11):48-52. DOI: 10.16305/j.1007-1334.2022.2112002.
基于中医理论溯源及临证观察,认为《内经》“心痹”理论与类风湿关节炎心血管损伤密切相关。结合“心痹”理论的内涵,认为类风湿关节炎合并心血管损伤以营卫失调为发病关键因素,初期为“邪居脉道”,后期以“邪痹于心”为病机特点;同时辨析类风湿关节炎心血管损伤的临床表现与“脉痹”“心痹”证候的相关性,提示临床治疗类风湿关节炎并发心血管损伤可用“豹刺”大陵、调和营卫法以益心通痹,以及巧用化瘀补虚诸药、少用辛燥之品以祛邪外出。
Based on the tracing of traditional Chinese medicine theory and clinical observation,it was believed that the theory of “heart paralysis” in, Neijing, was closely related to the cardiovascular injury of rheumatoid arthritis. Combined with the connotation of the theory of “heart paralysis”, it was believed that the disorder of ying and wei was the key factor in the pathogenesis of cardiovascular injury in rheumatoid arthritis. At the same time,the correlation between the clinical manifestations of cardiovascular injury in rheumatoid arthritis and the syndrome of “pulse paralysis” and “heart paralysis” was analyzed. It was suggested that the treatment of rheumatoid arthritis complicated with cardiovascular injury could be done by “bao ci” the acupoint of Daling and harmonizing ying and wei method to improve heart and relieve paralysis as well as removing blood stasis and tonifying deficiency drugs, and less spicy-dry drugs to remove pathogenic factors.
心痹类风湿关节炎痹证心血管疾病中医药疗法
heart paralysisrheumatoid arthritisarthralgiacardiovascular diseasetraditional Chinese medicine therapy
中华医学会风湿病学分会. 2018 中国类风湿关节炎诊疗指南[J]. 中 华 内 科 杂 志,2018, 57(4): 242-251.
YU C, LI M, DUAN X, et al. Chinese registry of rheumatoidarthritis(CREDIT):Ⅰ. introduction and prevalence of remission in Chinese patients with rheumatoid arthritis[J]. Clin Exp Rheumatol, 2018, 36(5): 836-840.
JIN S,LI M,FANG Y,et al. Chinese registry of rheumatoidarthritis(CREDIT):Ⅱ. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis[J]. Arthritis Res Ther, 2017, 19(1): 251.
DAS S,PADHAN P. An overview of the extraarticular involvement in rheumatoid arthritis and its management[J]. J Pharmacol Pharmacother, 2017, 8(3): 81-86.
赵鹏,蔡辉. 类风湿关节炎心脏损害的研究进展[J]. 微循环学杂志,2011, 21(3): 71-74.
RINCÓN I D,WILLIAMS K,STERN M P,et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors[J]. Arthritis Rheum,2001, 44(12): 2737-2745.
SIHVONEN S,KORPELA M,LAIPPALA P,et al. Death rates and causes of death in patients with rheumatoid arthritis:a population-based study[J]. Acta Rheumatologica Scandinavica, 2004, 33(4): 221-227.
刘贵艳,边森,李芳,等. 类风湿关节炎合并心血管损害危险因素及治疗的研究进展[J].中华临床医师杂志(电子版),2017, 11(3): 492-496.
史俊,季晨,雷鑫,等. 类风湿关节炎合并冠状动脉粥样硬化性心脏病的研究进展[J]. 新医学,2020, 51(7): 506-511.
杨洋,张晓红,黄鹤. 类风湿关节炎与心血管疾病相关性的研究进展[J]. 中国心血管杂志,2019, 24(6): 571-574.
李满意,娄玉钤. 五脏痹的源流[J]. 风湿病与关节炎,2013, 2(5): 36-42.
路志正,焦树德,闫孝诚. 痹病论治学[M]. 北京:人民卫生出版社,1989: 17-20, 133-146.
娄玉钤. 中国风湿病学[M]. 北京:人民卫生出版社,2001: 67-68.
胡志坚. 浅谈“五脏痹”[J]. 新中医,1982, 14(4): 1-4,16.
董振华. 从《内经》五脏痹理论探讨风湿病多系统损害的治疗[J]. 北京中医药,2006, 25(6): 347-350.
孙凤霞,周光. “营卫”功能与病机、证候特点探讨[J]. 新疆中医药,2009, 27(1): 20-21.
周东浩,房辉. 代谢和免疫相互作用稳态——复杂性科学视角下的营卫解读[J]. 中华中医药杂志,2008, 23(10): 856-859.
单媛,徐婧,王平,等. 类风湿关节炎合并冠心病临床病例资料回顾性分析[J]. 中国全科医学,2020, 23(S1): 58-60.
葛均波,徐永健,梅长林,等. 内科学[M]. 北京:人民卫生出版社,2013: 808.
DEL RINCON I, OLEAFY D H, FREEMAN G L, et al. Acceleration of atherosclerosis duringthe course of rheumatoid arthritis[J]. Atherosclerosis, 2007, 195(2): 354-360.
HANNAWI S, MARWICK T H, THOMES R. Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis[J]. Arthritis Res Ther, 2009, 11(2): R51.
BLUM A, ADAWI M. Rheumatoid arthritis(RA)and cardiovascular disease[J]. Autoimmun Rev, 2019, 18(7): 679-690.
陈磊,汪元,潘惠,等. 类风湿关节炎合并心血管疾病的危险因素分析[J]. 中华中医药杂志,2019, 34(1): 328-331.
RADOVITS B J, FRANSEN J, SHAMMA A S, et al. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis[J]. Arthritis Care Res(Hoboken), 2010, 62(3):362-370.
NAZ S M, FARRAGHER T M, BUNN D K, et al. The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis[J]. Arthritis Rheum, 2008, 58(4): 985-989.
张守彦,王显,胡大一. 类风湿性关节炎的心血管损害[J]. 心血管病学进展,2009, 30(6): 929.
HIPPISLEY C J, COUPLAND C, VINOGRADOVA Y, et al. Predicting cardiovascular risk in England and Wales:prospective derivation and validation of QRISK2[J]. BMJ, 2008, 336(7659): 1475-1482.
杨丽娜,李明,董全伟,等. 脉痹考辨[J]. 中华中医药杂志,2019, 34(1): 75-77.
李满意,娄玉钤. 心痹的源流及相关历史文献复习[J]. 风湿病与关节炎,2015, 4(3): 47.
阳丹,张雪竹. “五刺应五脏”之浅析《灵枢》五刺法的研究进展[J]. 甘肃医药,2020, 39(6): 488-491.
刘淼,吕晓东,白长川. 桂枝汤中桂枝、白芍调和营卫与通达血管内外相关性探析[J]. 河北中医,2019, 41(7): 1098-1101.
韩晓伟,周国锋,王永成,等. 调和营卫法治疗心血管疾病研究进展[J]. 辽宁中医药大学学报,2021, 23(1): 46-49.
任宝娣,徐鹏刚,王颖,等. 桂枝芍药知母加味汤对类风湿关节炎伴发心血管损害影响的随机对照临床研究[J]. 上海中医药杂志,2014, 48(8): 46-48.
刘蔚翔,姜泉. 类风湿关节炎“湿、热、瘀”病机理论探析[J]. 中医杂志,2020, 61(24): 2148-2153.
童学彪. 五脏痹实质探讨[J]. 南京中医药大学学报,1996, 12(6): 6-7,63.
刘滨,刘维,吴沅皞. 类风湿关节炎合并心脏损害的中医治疗[J]. 中华中医药杂志,2020, 35(6): 2956-2958.
0
浏览量
258
下载量
0
CSCD
4
CNKI被引量
关联资源
相关文章
相关作者
相关机构